Overview
Juan Lahuerta practices in Madrid, Spain. Mr. Lahuerta is rated as an Elite expert by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Follicular Lymphoma, Plasmacytoma, and Bone Marrow Transplant.
His clinical research consists of co-authoring 85 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 72 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Multiple MyelomaMr. Lahuerta isElite. Learn about Multiple Myeloma.
- Distinguished
- Smoldering Multiple MyelomaMr. Lahuerta isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Bone Marrow TransplantMr. Lahuerta isAdvanced. Learn about Bone Marrow Transplant.
- Follicular LymphomaMr. Lahuerta isAdvanced. Learn about Follicular Lymphoma.
- PlasmacytomaMr. Lahuerta isAdvanced. Learn about Plasmacytoma.
- Experienced
- AgranulocytosisMr. Lahuerta isExperienced. Learn about Agranulocytosis.
- Hemolytic Transfusion ReactionMr. Lahuerta isExperienced. Learn about Hemolytic Transfusion Reaction.
- Hepatic Venoocclusive Disease with Immunodeficiency
- Infantile NeutropeniaMr. Lahuerta isExperienced. Learn about Infantile Neutropenia.
- LeukemiaMr. Lahuerta isExperienced. Learn about Leukemia.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)